GGrantIndex
Sort

40,608 grants matching prostate cancer

Targeted Inhibition in Leukemia

$465,554
Nicolas Nassar · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · CA

Heparan Sulfate--a Novel Target for Cancer Therapeutics

$465,503
University Of California San Diego · U01 · FY2003 · CA

Quantitative DCEMRI of Prostate Cancer Correlation with Gold Standards

$465,411
Gregory S Karczmar · University Of Chicago · R01 · FY2017 · CA

Enhancement of tumor radiation response by ultrasound-driven nanobubble stimulation

$465,181
Agata A Exner · Case Western Reserve University · R01 · FY2023 · CA

Project 1

$465,101
Dan Theodorescu · University Of Virginia · P01 · FY2014 · CA

Web-Based Support for Informal Caregivers in Cancer

$465,070
University Of Wisconsin Madison · R01 · FY2005 · NR

Stromal Foxf2 suppresses prostate cancer progression

$465,029
Li Xin · University Of Washington · R01 · FY2023 · CA

Small Molecule PSMA-Targeted Alpha Therapy

$465,015
Martin G Pomper · Johns Hopkins University · R01 · FY2014 · CA

AR ALTERNATIVE POLYADENYLATION AS A THERAPEUTIC VULNERABILITY IN PROSTATE CANCER

$465,000
Regents Of The University Of Minnesota · · FY2022 · Defense Health Agency

LIGAND-TARGETED MIRNA DELIVERY FOR PROSTATE CANCER THERAPY

$465,000
Purdue University · · FY2021 · Department of the Army

Sensitive tumor detection with magnetomotive imaging

$464,983
Xiaohu Gao · University Of Washington · R01 · FY2015 · CA

Sensitive tumor detection with magnetomotive imaging

$464,983
Xiaohu Gao · University Of Washington · R01 · FY2012 · CA

NCTN - Network Lead Academic Participating Site: USC

$464,856
Heinz Josef Lenz · University Of Southern California · UG1 · FY2020 · CA

Non-coding RNAs for Epigenetic Transcriptional Silencing in Prostate Cancer

$464,838
Martin John Walsh · Icahn School Of Medicine At Mount Sinai · R01 · FY2014 · CA

Molecular Targets for Cancer Detection and Treatment

$464,808
Johns Hopkins University · T32 · FY2004 · CA

Prospective validation of a multi-marker prostate cancer prediction model

$464,784
Hans Gã–sta Lilja · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA

Targeting NSD1 in leukemia

$464,783
Tomasz Cierpicki · University Of Michigan At Ann Arbor · R01 · FY2021 · CA

Characterizing Mitochondrial DNA Susceptibility to Breast, Colorectal, and Prosta

$464,757
Iona C Cheng · University Of Hawaii At Manoa · R01 · FY2010 · CA

Role of BMP and FGF signaling during limb development

$464,718
Mark B Lewandoski · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

The Role of Fgf Signaling in Vertebrate Development

$464,718
Mark B Lewandoski · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Targeting Autophagy in Hereditary Breast Cancer

$464,713
Bing Xia · Rbhs -Cancer Institute Of New Jersey · R01 · FY2019 · CA

Microchannel cell-based assays to enable cancer research

$464,657
David J Beebe · University Of Wisconsin-Madison · R33 · FY2011 · CA

Anti-tumor Mechanisms &Therapeutic Effects of Vitamin D

$464,517
Roswell Park Cancer Institute Corp · R01 · FY2003 · CA

Quantitative DCEMRI of Prostate Cancer Correlation with Gold Standards

$464,511
Gregory S Karczmar · University Of Chicago · R01 · FY2016 · CA

Academic-Industrial Partnership for Translation of Acoustic Angiography

$464,504
Paul A Dayton · Univ Of North Carolina Chapel Hill · R01 · FY2014 · CA